Stanley Hsia to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications Stanley Hsia has written about Non-alcoholic Fatty Liver Disease.
Connection Strength
0.198
-
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nat Med. 2023 02; 29(2):392-400.
Score: 0.198
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.